Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists.
about
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseProliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.Proceedings of the 2014 National Toxicology Program Satellite SymposiumOncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot studySuccessful drug development despite adverse preclinical findings part 2: examples.Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsHistopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.Metastatic hemangiosarcoma of the liver in a young rat.Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.CKD-501, a novel selective PPARγ agonist, shows no carcinogenic potential in ICR mice following oral administration for 104 weeks.Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studies.Proliferative and molecular effects of the dual PPARalpha/gamma agonist tesaglitazar in rat adipose tissues: relevance for induction of fibrosarcoma.Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.Evaluation of expression profiles of hematopoietic stem cell, endothelial cell, and myeloid cell antigens in spontaneous and chemically induced hemangiosarcomas and hemangiomas in mice.Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".Dedifferentiated retroperitoneal liposarcoma spontaneously occurring in an aged SD rat.
P2860
Q28079801-7B23222A-51BE-4C84-81EF-4EB5E86002E7Q33880079-6DBD20E6-3284-4C15-B8E2-DFEF5CF15641Q35027722-5BED15BB-DD43-4AD4-B70A-EB4DDF40D381Q35155743-D951C3D7-8D8B-4C04-8A10-CF069638092FQ35603965-42DFFD82-BBE0-41DF-B4D2-9A70438A7ECFQ35603973-84FE1569-CB7A-4BB1-9300-A7A0CBD63C4EQ37262697-4ADAADE1-2DA7-4940-893B-96C52301554AQ37626950-121493D9-9989-4BE6-B25A-B7C077DA34B9Q37824547-34969D04-ED85-4E5E-B81F-3869C23A00BCQ38446975-ADED0E5C-03CC-4B04-9B5F-4AECC7F7E21DQ39470072-62ABB2FE-0D82-4206-8BDA-B6B2DA92C6D2Q42723223-EDA3DF01-9346-4842-969B-BA0D4DE5A080Q42754588-2ADDD272-AE0F-45F6-9B97-F038BC939F32Q43287595-6AA550A6-DC0B-49B1-B80B-E0DBA1A3CEDBQ45125632-C22EAEE6-67B1-420C-A6C9-0F1570436B27Q53302209-AF058D49-949E-4AC6-97E2-60C5198BB06EQ55016462-BCD8E023-5B79-4813-AF8B-4FB1810DAD31
P2860
Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@ast
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@en
type
label
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@ast
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@en
prefLabel
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@ast
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@en
P2093
P2860
P1476
Histopathology of hemangiosarc ...... associated with PPAR agonists.
@en
P2093
David E Malarkey
Heinrich Ernst
Holly Kolenda-Roberts
Jerry F Hardisty
Michael R Elwell
Peter C Mann
Peter Greaves
Pierre A Tellier
P2860
P304
P356
10.1080/01926230701748156
P407
P577
2007-12-01T00:00:00Z